Back to Search Start Over

Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population

Authors :
Omer Ben-Yoseph
Ayala Frumkin
Marcia Zeigler
Edna Ben Asher
T. Olender
Gideon Bach
Yechiel Friedlender
Annick Raas-Rothschild
Ruth Bargal
Nili Avidan
Doron Lancet
Source :
Human mutation. 17(5)
Publication Year :
2001

Abstract

The gene MCOLN1 is mutated in Mucolipidosis type IV (MLIV), a neurodegenerative, recessive, lysosomal storage disorder. The disease is found in relatively high frequency among Ashkenazi Jews due to two founder mutations that comprise 95% of the MLIV alleles in this population [Bargal et al., 2000]. In this report we complete the mutation analysis of Jewish and non-Jewish MLIV patients whose DNA were available to us. Four novel mutations were identified in the MCOLN1 gene of severely affected patients: two missense, T232P and F465L; a nonsense, R322X; and an 11-bp insertion in exon 12. The nonsense mutation (R322X) was identified in two unrelated patients with different haplotypes in the MCOLN1 chromosomal region, indicating a mutation hotspot in this CpG site. An in-frame deletion (F408del) was identified in a patient with unusual mild psychomotor retardation. The frequency of MLIV in the general Jewish Ashkenazi population was estimated in a sample of 2,000 anonymous, unrelated individuals assayed for the two founder mutations. This analysis indicated a heterozygotes frequency of about 1/100. A preferred nucleotide numbering system for MCOLN1 mutations is presented and the issue of a screening program for the detection of high-risk families in the Jewish Ashkenazi population is discussed. Hum Mutat 17:397–402, 2001. © 2001 Wiley-Liss, Inc.

Details

ISSN :
10981004
Volume :
17
Issue :
5
Database :
OpenAIRE
Journal :
Human mutation
Accession number :
edsair.doi.dedup.....0e987055971bbdf46e91adaddabf08b6